Description: Discusses the influences that foreign economies have on the U.S. economy and the risks that those influences create for the U.S. life insurance industry.

Description: Discuss a comparison of the U.S. general and insured population mortality experience and how COVID-19 and non-COVID-19 excess deaths impacted the populations differently. Discover the population mortality experience in the UK with a focus on the recent emergence of excess deaths for non-COVID causes. The long-term implications on the insured population will also be explored. Wrap up with a discussion of different conditions of long COVID, including organ impairments.

Description: Actuaries are increasingly being asked to incorporate Economic Scenario Generators into their work. Whether it be a Risk Neutral model for pricing or a Real-World version for Economic Capital modelling, using these tools can help produce a much more robust analysis. Unfortunately, these models and their underpinnings are also very complicated, which can lead to confusion. The presenters in this session will try to demystify some of this. In particular, they will address the following questions: • What is the difference between Real-World and Risk Neutral scenarios? • When should I use one or the other? • How are these models calibrated? • What are some of the misconceptions about these models?

Description: 2021 ImpACT Conference - Session 13E: Managing Cognitive Bias in ERM Processes 10.29.21 Recording

Description: Explore the value and cost of prescription drugs, how they should be defined and measured and the effects various stakeholders in the pharmacy ecosystem can have on these factors in the latest webcast. You'll investigate the impact of coverage, formulary and rebate negotiations and related benefit design. Find out how actuaries can answer questions related to the prescription drug industry, in addition to improving the access, quality and affordability of prescription drugs in the United States. Join us for this webcast and come learn about value-based contract design, negotiations, implementation and administration for prescription drugs.

Description: Re/insurance rates have been increasing since 2018, although pricing momentum has decelerated recently. Insurers and reinsurers are working to enhance profitability and improve the value proposition for clients in an environment of uncertainty about natural catastrophes, COVID-19-related losses, and social inflation, among other factors. This article describes drivers of the current underwriting cycle, compares it with past cycles, and provides considerations for the future.

Description: This article is part of a 2 part series on real options analysis (ROA). Before you can understand the limitations of ROA, you must first understand the difference between risk and uncertainty. This article goes into detail explaining the vast differences between the two phenomena.

Description: Many countries have suffered the ups and downs of the COVID-19pandemic, and Mexico is no exception. Even worse, in contrast withEuropean countries that saw numbers dip during the summer of2020, Mexico did not. A first peak was reached at the end of July2020, then a slight decrease in the following two months. SinceOctober, Mexico has experienced the worst increasing trend of thewhole epidemic. In this article, Arturo Erdely, a professor of actuarialscience, explains this increase.

Description: This article was written in June 2008, prior to the financial crisis in the fall of 2008. It discusses the very complicated new world of financial insturments and derivatives and the risks that there may be in light of no strong capital requirements, no control on leverage and the high derivative volume.

Description: Editorial discussing the tumultuous insurance industry and current financial crisis.